GeNeDis 2020: Computational Biology and Bioinformatics

The 4th World Congress on Genetics, Geriatrics, and Neurodegenerative Diseases Research (GeNeDis 2020) focuses on scientific research, drug targets, biomarkers, imaging techniques, and early diagnosis of neurodegenerative diseases for better, safer, and healthier aging. Computational methodologies for biomarker discovery are discussed.

Format: Paperback / softback
Length: 288 pages
Publication date: 21 December 2022
Publisher: Springer Nature Switzerland AG

The 4th World Congress on Genetics, Geriatrics, and Neurodegenerative Diseases Research (GeNeDis 2020) serves as a pivotal platform for addressing the most pressing challenges in scientific research, exploring novel drug targets, developing innovative biomarkers, advancing novel imaging techniques, and developing novel protocols for early diagnosis of neurodegenerative diseases. With the ultimate goal of promoting better, safer, and healthier aging, the congress brings together experts from diverse fields to exchange knowledge and foster advancements in this critical area.

Computational methodologies play a crucial role in the discovery of biomarkers for neurodegenerative diseases. This volume specifically highlights the sessions from the conference that delve into computational biology and bioinformatics, providing a comprehensive understanding of the latest developments and applications in these fields.

The congress offers a rich tapestry of presentations and discussions, covering a wide range of topics related to genetics, geriatrics, and neurodegenerative diseases. Key speakers, renowned researchers, and industry professionals share their insights, cutting-edge research findings, and clinical experiences, fostering a collaborative environment for knowledge sharing and innovation.

One of the significant highlights of GeNeDis 2020 is the emphasis on developing novel drug targets and therapies for neurodegenerative diseases. The congress provides a platform for exploring new therapeutic approaches, such as gene therapy, stem cell therapy, and nanotechnology, which hold the potential to revolutionize the treatment of these debilitating conditions.

In addition to drug development, the congress also focuses on the development of innovative biomarkers and imaging techniques. These tools play a vital role in early diagnosis, monitoring disease progression, and personalized treatment strategies for neurodegenerative diseases. By identifying specific biomarkers and developing accurate imaging methods, researchers can improve the accuracy and efficiency of diagnosis, enabling timely intervention and better patient outcomes.

Another important aspect of GeNeDis 2020 is the exploration of novel protocols for early diagnosis of neurodegenerative diseases. With the increasing prevalence of these conditions, there is a critical need for efficient and cost-effective diagnostic methods that can be widely accessible. The congress aims to address this challenge by presenting and discussing innovative protocols, including genetic testing, imaging biomarkers, and computational methodologies, that can aid in early detection and intervention.

Furthermore, the congress addresses the broader societal implications of neurodegenerative diseases, including the impact on healthcare systems, social welfare, and quality of life. By fostering interdisciplinary collaboration and promoting public awareness, GeNeDis 2020 aims to raise awareness about these diseases, encourage research and development efforts, and provide support to individuals and families affected by neurodegenerative disorders.

In conclusion, the 4th World Congress on Genetics, Geriatrics, and Neurodegenerative Diseases Research (GeNeDis 2020) serves as a landmark event that brings together experts from diverse fields to address the most pressing challenges in scientific research, drug development, biomarker discovery, imaging techniques, and early diagnosis of neurodegenerative diseases. By fostering collaboration, promoting knowledge sharing, and driving innovation, GeNeDis 2020 plays a vital role in advancing our understanding of these complex conditions and improving the lives of individuals affected by neurodegenerative diseases.

Weight: 588g
Dimension: 254 x 178 (mm)
ISBN-13: 9783030787776
Edition number: 1st ed. 2021